Phase II trial of simple oral therapy (continuous oral cyclophosphamide and capecitabine) in patients with metastatic breast cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Cyclophosphamide
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 18 Jul 2013 Biomarkers information updated
- 01 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Aug 2007 Status change from recruiting to in progress.